Clinical and Laboratory Characteristics of Drug-induced Vasculitic Syndromes
Overview
Authors
Affiliations
Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase-antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare.
Khalaf R, Mhesin D, Abu Salim H, Taha S, Abed W Clin Diabetes Endocrinol. 2024; 10(1):42.
PMID: 39587631 PMC: 11587566. DOI: 10.1186/s40842-024-00215-3.
Galip N, Ankay N, Bundak R J Clin Res Pediatr Endocrinol. 2021; 15(3):307-311.
PMID: 34763385 PMC: 10448555. DOI: 10.4274/jcrpe.galenos.2021.2021.0205.
Wriston D, Norfolk E, Smith L, Chen G, Bulbin D Case Rep Rheumatol. 2020; 2020:3853671.
PMID: 32908768 PMC: 7474355. DOI: 10.1155/2020/3853671.
Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
Weng C, Liu Z Chin Med J (Engl). 2019; 132(23):2848-2855.
PMID: 31856057 PMC: 6940077. DOI: 10.1097/CM9.0000000000000539.
Drug-induced glomerular disease: immune-mediated injury.
Hogan J, Markowitz G, Radhakrishnan J Clin J Am Soc Nephrol. 2015; 10(7):1300-10.
PMID: 26092827 PMC: 4491282. DOI: 10.2215/CJN.01910215.